Pathway Genomics Corp. (San Diego, Calif.) said it raised more than $40 million in a series E round from investors including the IBM Watson unit of IBM Corp. (NYSE: IBM). Pathway said it expects to...
Myriad filed suit against Pathway in the U.S. District Court for the District of Utah, Central division alleging that Pathway’s BRCATrue gene test infringes 13 Myriad patents related to the breast cancer 1 early onset...
Pathway Genomics launched its BRCATrue gene test worldwide along with the One for One program, through which it has committed to donate up to $10 million in free breast cancer 1 early onset (BRCA1) and...